Schonfeld Strategic Advisors LLC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1665241
NEW YORK, NY
Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$176,836
-$250,762 QoQ
Shares Held
26,315
-62.3% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 133 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Derivatives in ARCT
reported options exposure · as of Jun 30, 2022CallValue
$3,628,070
CallShares
230,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. ARCT ranks #105 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,836 | 26,315 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $427,598 | 69,755 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,308,051 | 667,827 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,205,135 | 784,407 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,744,861 | 825,766 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,408,904 | 849,081 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,578,392 | 369,599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,901,277 | 283,420 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,701,102 | 346,494 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,658,695 | 401,481 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,737,835 | 107,156 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $616,022 | 41,567 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,211,976 | 267,597 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $3,628,070 | 230,500 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $2,051,548 | 76,096 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,063,233 | 55,748 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $10,177,750 | 275,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $2,389,000 | 50,000 | Call | Sole | 2021-11-16 | |
| 2021-09-30 | $4,807,958 | 100,627 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $796,322 | 23,532 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $793,290 | 19,208 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,529,925 | 35,268 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,145,000 | 50,000 | Call | Sole | 2020-11-19 | |
| 2020-09-30 | $7,051,473 | 164,370 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $908,485 | 19,437 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||